Philippe de Lavenne
Group CEO at Perha Pharmaceuticals- Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Gold Feature
Click to upgrade to our gold package
for the full feature experience.
Location
FR
Topline Score
Topline score feature will be out soon.
Bio
Generated by
Topline AI
You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now
Experience
-
Perha Pharmaceuticals
-
France
-
Biotechnology Research
-
1 - 100 Employee
-
Group CEO
-
Apr 2019 - 4 years 9 months
Paris - Roscoff
-
-
-
-
Group CEO
-
Feb 2018 - 5 years 11 months
-
-
-
-
Vice-President Europe, Canada, Latin America, Middle East and Africa
-
2008 - 2017
Vice-President Europe, Canada, Latin America, Middle East and Africa at Actelion Pharmaceuticals (Swiss company - orphan drugs), until the company was sold for $30B to J&J.
-
-
-
-
Senior Vice-President
-
2005 - 2008
Senior Vice-President at Altana - Nycomed (German – Danish company). Global head of OTC Business and Specialty Products Regional Director.
-
-
-
Sanofi
-
France
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Managing Director & Associate VP
-
1998 - 2004
Managing Director Mexico then as Associate VP for Latin America
-
-
-
Servier
-
France
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
General Manager
-
1987 - 1998
General Manager for Denmark (88), the Netherlands (89-92), Spain (93- 94) and France (94-98). Member of the executive committee from 94 to 98
-
-
-
PIERRE FABRE PHARMACEUTICALS, INC.
-
United States
-
Chemical Manufacturing
-
1 - 100 Employee
-
Marketing manager
-
1985 - 1987
-
-
-
-
Product Manager
-
1983 - 1985
-
-
Education
-
1982 - 1984
HEC Paris
-
1974 - 1982
Necker Enfants-Malades
Doctorat, Medicine
Community
You need to have a working account to view this content.
Click here to join now
